|
| Bothell biotech submits drug for approval |
1 May 08, 01:34 |
|
| MediQuest Therapeutics Inc. of Bothell has submitted a new drug application to the U.S. Food and Drug Administration for MQX-503, a topical formulation designed to treat Raynaud's Disease, which can cause pain in hands, feet and other extremities when they are exposed to cold temperatures. |
| more |
|
